tiprankstipranks
Trending News
More News >
Ironwood Pharma (IRWD)
NASDAQ:IRWD
US Market

Ironwood Pharma (IRWD) Income Statement

Compare
311 Followers

Ironwood Pharma Income Statement

Last quarter (Q1 2025), Ironwood Pharma's total revenue was $41.14M, a decrease of -45.05% from the same quarter last year. In Q1, Ironwood Pharma's net income was $-37.39M. See Ironwood Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 351.41M$ 442.74M$ 410.60M$ 413.75M$ 389.52M
Gross Profit
$ 351.41M$ 337.95M$ 409.18M$ 412.23M$ 382.82M
Operating Expenses
$ 258.29M$ 232.12M$ 160.26M$ 181.49M$ 228.06M
Depreciation and Amortization
$ 2.01M$ 1.57M$ 1.42M$ 1.52M$ 3.56M
EBITDA
$ 100.24M$ -924.87M$ 261.44M$ 233.33M$ 141.90M
Operating Income
$ 93.12M$ -945.43M$ 250.34M$ 232.26M$ 142.94M
Other Income/Expenses
$ -27.93M$ -2.64M$ 2.08M$ -31.60M$ -34.08M
Pretax Income
$ 65.20M$ -948.07M$ 252.42M$ 200.66M$ 108.86M
Net Income
$ 880.00K$ -1.00B$ 175.06M$ 528.45M$ 106.18M
Per Share Metrics
Basic EPS
$ 0.01$ -6.45$ 1.13$ 3.26$ 0.67
Diluted EPS
$ 0.01$ -6.45$ 0.94$ 3.21$ 0.66
Weighted Average Shares Outstanding
159.08M 155.44M 154.37M 162.25M 159.43M
Weighted Average Shares Outstanding (Diluted)
160.08M 155.44M 186.31M 164.42M 160.66M
Currency in USD

Ironwood Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis